Read the full research online: http://heart.bmj.com/content/99/23/1734

In 2010, the Department of Health in England introduced an incentivised national target for National Health Service (NHS) hospitals aiming to increase the number of patients assessed for the risk of developing venous thromboembolism (VTE) associated with hospital admission.

Will Lester, from the Quality and Outcomes Research Unit at the University Hospital Birmingham, and colleagues assessed the impact of this initiative on VTE mortality and subsequent readmission with non-fatal VTE.

He joins Alistair Lindsey to talk about the study.

Catherine Otto, Heart's editor in chief, interviews April Stempien-Otero from the University of Washington, at the American Heart Association meeting in Dallas.

They discuss Dr Stempien-Otero's late breaking clinical trial, presented at the meeting, which looks at the use of bone marrow derived stem cells, and their use in ischemic cardiomyopathy with LVAD bridge to transfer.

Patrick Calvert interviews Alain Cribier, Director of Cardiology at Charles Nicolle Hospital, University of Rouen in France, and pioneer in the field of aortic and mitral valvuloplasty.

Patrick Calvert interviews Alec Vahanian, Head of the Cardiology Department, Bichat University Hospital, Paris at the annual British Cardiovascular Society meeting in London.

Alistair Lindsay interviews Anthony De Maria, director of the Cardiovascular Center at the UC San Diego medical school, and current Editor in Chief of JACCE.

As we near ten years since the first transcatheter aortic vale implantation, Alistair Lindsey, Heart’s JournalScan editor, talks to Philip MacCarthy, consultant cardiologist, King’s College Hospital, about his work examining how the ventricle responds following the procedure.

See also:

Successful transcatheter aortic valve implantation (TAVI) is associated with transient left ventricular dysfunction http://bit.ly/12Fwwcf

Mark de Belder (consultant cardiologist in Middlesbrough) talks to James McLenachan (consultant cardiologist in Leeds) and Keith Channon (professor of Cardiovascular Medicine, University of Oxford) about the pathophysiology and management of acute coronary syndromes.

See also:

Webcasts from all the sessions at the British Cardiovascular Society Conference 2012 bit.ly/ZMGmUE

Guy Lloyd (a consultant cardiologist in Eastbourne) talks to Gerry McCann (a cardiologist in Leicester) and John Chambers (president of the British Heart Valve Society) about aortic valve disease.

They discuss stratifying cases by risk, myocardial fibrosis, the various assessments available, whether clinicians should be looking more to prescribe ACE inhibitors, and how best valve service should be configured.

See also:

Postconditioning and protection from reperfusion injury: where do we stand? http://bit.ly/15EmdIy

Webcasts from all the sessions at the British Cardiovascular Society Conference 2012 bit.ly/ZMGmUE

Michael Marber (professor of Cardiology at King’s College London) discusses reperfusion injury with Michel Ovize (professor at the Hôpitaux de Lyon).

See also:

Postconditioning and protection from reperfusion injury: where do we stand?http://bit.ly/15EmdIy

Webcasts from all the sessions at the British Cardiovascular Society Conference 2012 http://bit.ly/ZMGmUE

Jim Hall (BCS vice-president for training, and chairman of the SAC) talks to Thanh Phan (SPL trainee from the Northern Deanery) about current issues in cardiology training. These include Workplace Based Assessments, clinical genetics, and workforce projections.

See also:

Webcasts from all the sessions at the British Cardiovascular Society Conference 2012 http://bit.ly/ZMGmUE